参考文献/References:
1 Zetter BR. On target with tumor blood vessel markers. Nat Biotechnol, 1997, 15(12):1243-1244.
2 Janssen M. Oyen W J, Massuger L F, et al. Comparison of a monomeric and dimeric radiolabeled RGD-peplide for tumor targeling. Cancer Biother Radiopharm, 2002, 17(6):641-646.
3 Schraa AJ, Kok R J, Moorlag HE, et al. Targeting of RGD-modified proteins to tumor Vasculature:a pharmacokinetic and cellular distribution study. Int J Cancer, 2002,102(5):469-475.
4 Pasqualini R, Koivtmen E, Ruoslahti E. A peptide isolated from phage display libraries is a structural and functional mimic of an RGD-binding site on integrins. J Cell Biol, 1995, 130(5):1189-1196.
5 Pasqualini R, Ruoslahti E. Organ targeting in vivo using phage displaypeptide libraries. Nature, 1996,380(6572):364-366.
6 Rajotte D, Arap W, Hagedorn M, et al. Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display. J Clin Invest, 1998, 102(2):430-437.
7 Haubner R, Wester HJ, Weber WA, et al. Noninvasive imaging of αvβ3 integrin expression using 18F-labeled-RGD-containing glycopeptide and positron emission tomography. Cancer Res, 2001, 61(5):1781-1785.
8 Su Z.F, Liu G, Gupta S, et al. In vitro and in vivo evaluation of a 99mTechnetium-labeled cyclic RGD peptide as a specific marker of alpha(V) beta (3) integrin for tumor imaging. Bioconjug Chem, 2002, 13(3):561-570.
9 Zitzmann S, Ehemann V, Schwab M. Arginine-glycine-aspartic acid (RGD)-peptide binds to both tumor and tumor-endothelial cells in vivo. Cancer Res, 2002,62(15):5139-5143.
10 Achilefu S, Blnch S, Markiewicz MA, et al. Synergistic effects of lightemitting probes and peptides for targeting and monitoring integrin expression. Proc Natl Acal Sci USA, 2005, 102(22):7976-7981.
11 Ye Yp, Bloch S, Xu B. Design synthesis and evaluation of near infrared florescent mehimeric RGD peptides for targeting tumors. J Med Chem. 2006, 49(7):2268-2275.
12 李前伟,王曙光,郑秀海,等.125I-RGD-4CY肿瘤αvβ3受体显像的实验研究.第三军医大学学报,2002,24(11):1340-1342.
13 程绍钧,李前伟,李忠俊,等.以血管生成为靶点的肿瘤核素显像及治疗的实验研究.第三军医大学学报,2005,27(2):109-111.
14 Kok R J, Schraa AJ, Bos EJ, et al. Preparation and functional evaluation of RGD-modified proteins as alpha(v)heta(3) integrin direeted herapeuties. Bioconjug Chore, 2002, 13(1):128-135.
15 Buerkle MA, Pahernik SA, Sutter A, et al. Inhibition of the alphanu integrins with a cyclic RGD peptide impairs angiogenesis,growth and metastasis of solid turnouts in vivo. Br J Cancer, 2002, 86(5):788-795.
16 Burkhart DJ, Kalet BT, Coleman MP, et al. Doxorubicin-formaldehyde conjugates targeting αvβ3 integrin. Mol Cancer Ther, 2004, 3(12):1593-1604.
17 Curnis F, Sacchi A, Cortt A. Improving chemotherapeutic drug penetra-tion in tumors by vascular targeting and barrier alteration. J Clin Invest, 2002, 110(4):475-482.
18 Curnis F, Gasparri A, Sacchi A, et al. Coupling tumor necrosis factor-alpha with alphaV integriu ligands improves its antineoplastic activity. Cancer Res 2004, 64(2):565-571.
19 王芳,蒋建伟,曾慧兰,等.整合素受体介导bcl-2反义核酸联合化疗药物对大肠癌细胞的增殖抑制作用.实用医学杂志,2006,22(7):748-749.
20 熊小兵,黄悦,吕万良,等.RGD类似物修饰的阿霉素隐形脂质体的制备及体外细胞结合试验.药学学报,2005,40(12):1085-1090.
21 邱峰,陈世知,陈虹,等.新型腺病毒载体的制备及其特性研究.重庆医科大学学报,2006,31(3):330-333.
22 Dijkgraaff I, Kruijtzer JA, Lin S, et al. Improved targeting of the αvβ3 integrin by muhimerisation of RGD peptides. Eur J Nucl Med Mol Imaging, 2007, 34(2):267-273.
23 Halahan DE, Qu S, Geng L, et al. Radialion-medialed control of drug delivery. Am Clin Oncol, 2001, 24(5):473-480.
相似文献/References:
[1]邢宇,赵新明.放射性核素标记HER2亲和体分子探针精准诊疗的研究进展[J].国际放射医学核医学杂志,2016,40(2):139.[doi:10.3760/cma.j.issn.1673-4114.2016.02.011]
Xing Yu,Zhao Xinming.Advances in radionuclide-labeled HER2 affibody molecular probes for precise diagnosis and treatment[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):139.[doi:10.3760/cma.j.issn.1673-4114.2016.02.011]
[2]马乐,张万春,李晓敏.乳腺癌前哨淋巴结核素显像新进展[J].国际放射医学核医学杂志,2016,40(2):145.[doi:10.3760/cma.j.issn.1673-4114.2016.02.012]
Ma Le,Zhang Wanchun,Li Xiaomin.Evolution of radionuclide imaging of sentinel node lymphscintigraphy in breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):145.[doi:10.3760/cma.j.issn.1673-4114.2016.02.012]
[3]陈顺军,程兵.肿瘤细胞凋亡核素显像分子探针研究进展[J].国际放射医学核医学杂志,2016,40(2):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
Chen Shunjun,Cheng Bing.Progress in molecular probes of radionuclide tumor apoptosis imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
[4]孙芳芳,张欣.uPAR放射性核素靶向显像研究进展[J].国际放射医学核医学杂志,2016,40(3):230.[doi:10.3760/cma.j.issn.1673-4114.2016.03.013]
Sun Fangfang,Zhang Xin.Research progress of uPAR-targeted nuclear imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):230.[doi:10.3760/cma.j.issn.1673-4114.2016.03.013]
[5]安淑娴,宋少莉,黄钢.放射性核素标记的凋亡显像剂的研究进展[J].国际放射医学核医学杂志,2015,39(6):470.[doi:10.3760/cma.j.issn.1673-4114.2015.06.008]
An Shuxian,Song Shaoli,Huang Gang.Recent advances in apoptosis imaging using radionuclide-labeled tracers[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):470.[doi:10.3760/cma.j.issn.1673-4114.2015.06.008]
[6]黄建敏,解朋,刘晓梅,等.以整合素αvβ3为靶点的肿瘤分子显像及靶向治疗[J].国际放射医学核医学杂志,2015,39(3):256.[doi:10.3760/cma.j.issn.1673-4114.2015.03.015]
Huang Jianmin,Xie Peng,Liu Xiaomei,et al.Integrins αvβ3 in molecular imaging and targeted therapy of neoplasms[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):256.[doi:10.3760/cma.j.issn.1673-4114.2015.03.015]
[7]郭宵峰,刘建中,孙琦婷.肺通气/灌注平面显像与肺灌注SPECT/CT对肺栓塞诊断价值的对比性研究[J].国际放射医学核医学杂志,2015,39(4):277.[doi:10.3760/cma.j.issn.1673-4114.2015.04.001]
Guo Xiaofeng,Liu Jianzhong,Sun Qiting.Comparative study of pulmonary ventilation/perfusion planar imaging and pulmonary perfusion SPECT combined with low-dose CT in the diagnosis of pulmonary embolism[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):277.[doi:10.3760/cma.j.issn.1673-4114.2015.04.001]
[8]马春旭,袁卫红.甲状腺结节影像学诊断研究进展[J].国际放射医学核医学杂志,2014,38(1):48.[doi:10.3760/cma.j.issn 1673-4114.2014.01.010]
Ma Chunxu,Yuan Weihong.Advanced research on imaging diagnosis of thyroid nodule[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(5):48.[doi:10.3760/cma.j.issn 1673-4114.2014.01.010]
[9]吕靖,张一帆.核素分子显像监测胚胎干细胞及诱导性多潜能干细胞移植的研究进展[J].国际放射医学核医学杂志,2014,38(2):106.[doi:10.3760/cma.j.issn.1673-4114.2014.02.009]
Lyu Jing,Zhang Yifan.Advances in radionuclide imaging of monitoring embryonic stem cells and induced pluripotent stem cells transplantation[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(5):106.[doi:10.3760/cma.j.issn.1673-4114.2014.02.009]
[10]高平,王茜,赵赟赟,等.99Tcm-MDP SPECT/CT显像用于骨肉瘤肺转移的诊断[J].国际放射医学核医学杂志,2014,38(3):148.[doi:10.3760/cma.j.issn.1673-4114.2014.03.002]
Gao Ping,Wang Qian,Zhao Yunyun,et al.99Tcm-MDP SPECT/CT used in diagnosis of pulmonary metastasis from osteosarcoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(5):148.[doi:10.3760/cma.j.issn.1673-4114.2014.03.002]
[11]刘晓飞,张锦明,王洁磊,等.放射性核素标记RGD序列多肽与整合素αvβ3受体显像的研究进展[J].国际放射医学核医学杂志,2008,32(1):12.
LIU Xiao-fei,ZHANG Jin-min,WANG Jie-lei,et al.Study progress of malignant tumor imaging of integrin αvβ3 expression with radioisotope labelled RGD peptides[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(5):12.
[12]陈素芸.放射性核素标记RGD多肽在整合素受体显像中的应用[J].国际放射医学核医学杂志,2007,31(3):129.
CHEN Su-yun.Application of radiolabeled RGD peptides in imaging of integrin receptor[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(5):129.